Efficacy of a New Topical Anesthetic

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

A new topical anesthetic which contains 5% lidocaine and a disinfection ingredient has been developed and is tested in this study (LidoDyn).

The study examines the efficacy of LidoDyn by comparing it with an already proven anesthetic agent (EMLA crème).

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Rambam Health Care Campus
• Treatments: Anesthetics

Criteria

Inclusion Criteria:

• Previously healthy children of whom venipuncture is needed to be performed.

Exclusion Criteria:

• History of allergic reaction to any local anesthetic.

• History of chronic disease

• Patient's condition requires urgent treatment (e.g. severe dehydration, shock)

• Active local skin infection or skin pathologic condition at the antecubital fossa

• Tattoo, surgical scar or skin condition that might interfere with skin sight assessment.

• Patient undergone venipuncture at the antecubital fossa within the pror two weeks.

• Uncooperative or exceptionally anxious patient.